Current progress in epigenetic research for hepatocarcinomagenesis
- PMID: 19152082
- DOI: 10.1007/s11427-009-0014-7
Current progress in epigenetic research for hepatocarcinomagenesis
Abstract
Hepatocellular carcinoma is the main type of primary liver cancer, and also one of the most malignant tumors. At present, the pathogenesis mechanisms of liver cancer are not entirely clear. It has been shown that inactivation of tumor suppressor genes and activation of oncogenes play a significant role in carcinogenesis, caused by the genetic and epigenetic aberrance. In the past, people generally thought that genetic mutation is a key event of tumor pathogenesis, and somatic mutation of tumor suppressor genes is in particular closely associated with oncogenesis. With deeper understanding of tumors in recent years, increasing evidence has shown that epigenetic silencing of those genes, as a result of aberrant hypermethylation of CpG islands in promoters and histone modification, is essential to carcinogenesis and metastasis. The term epigenetics refers to heritable changes in gene expression caused by regulation mechanisms, other than changes in the underlying DNA sequence. Specific epigenetic processes include DNA methylation, genome imprinting, chromotin remodeling, histone modification and microRNA regulations. This paper reviews recent epigenetics research progress in the hepatocellular carcinoma study, and tries to depict the relationships between hepatocellular carcinomagenesis and DNA methylation as well as microRNA regulation.
Similar articles
-
Epigenetic alterations in preneoplastic and neoplastic lesions of the cervix.Clin Epigenetics. 2012 Aug 31;4(1):13. doi: 10.1186/1868-7083-4-13. Clin Epigenetics. 2012. PMID: 22938091 Free PMC article.
-
Epigenetics of hepatocellular carcinoma: a new horizon.Chin Med J (Engl). 2012 Jul;125(13):2349-60. Chin Med J (Engl). 2012. PMID: 22882861 Review.
-
Review of genetic and epigenetic alterations in hepatocarcinogenesis.J Gastroenterol Hepatol. 2006 Jan;21(1 Pt 1):15-21. doi: 10.1111/j.1440-1746.2005.04043.x. J Gastroenterol Hepatol. 2006. PMID: 16706806 Review.
-
DNA methylation in hepatocellular carcinoma.World J Gastroenterol. 2008 Mar 21;14(11):1741-8. doi: 10.3748/wjg.14.1741. World J Gastroenterol. 2008. PMID: 18350605 Free PMC article. Review.
-
Integrative analysis of aberrant Wnt signaling in hepatitis B virus-related hepatocellular carcinoma.World J Gastroenterol. 2015 May 28;21(20):6317-28. doi: 10.3748/wjg.v21.i20.6317. World J Gastroenterol. 2015. PMID: 26034368 Free PMC article. Review.
Cited by
-
MicroRNA-377 suppresses cell proliferation and invasion by inhibiting TIAM1 expression in hepatocellular carcinoma.PLoS One. 2015 Mar 4;10(3):e0117714. doi: 10.1371/journal.pone.0117714. eCollection 2015. PLoS One. 2015. Retraction in: PLoS One. 2022 Mar 24;17(3):e0266302. doi: 10.1371/journal.pone.0266302. PMID: 25739101 Free PMC article. Retracted.
-
New Insights into the Epigenetics of Hepatocellular Carcinoma.Biomed Res Int. 2017;2017:1609575. doi: 10.1155/2017/1609575. Epub 2017 Mar 19. Biomed Res Int. 2017. PMID: 28401148 Free PMC article. Review.
-
Downregulation of KIF1B mRNA in hepatocellular carcinoma tissues correlates with poor prognosis.World J Gastroenterol. 2015 Jul 21;21(27):8418-24. doi: 10.3748/wjg.v21.i27.8418. World J Gastroenterol. 2015. PMID: 26217094 Free PMC article.
-
Clinicopathological and prognostic significance of CDH1 hypermethylation in hepatocellular carcinoma: a meta-analysis.Cancer Manag Res. 2019 Jan 17;11:857-864. doi: 10.2147/CMAR.S179710. eCollection 2019. Cancer Manag Res. 2019. PMID: 30697077 Free PMC article.
-
A comprehensive analysis of the dynamic biological networks in HCV induced hepatocarcinogenesis.PLoS One. 2011 Apr 19;6(4):e18516. doi: 10.1371/journal.pone.0018516. PLoS One. 2011. PMID: 21526182 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
Miscellaneous